• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG-PET 和磁共振成像对预测轻度认知障碍向阿尔茨海默病转化的价值的长期研究:一项多中心研究。

Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.

机构信息

Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Aichi, Japan.

Department of Radiology, Fujita Health University School of Medicine, Aichi, Japan.

出版信息

J Alzheimers Dis. 2017;60(3):877-887. doi: 10.3233/JAD-170395.

DOI:10.3233/JAD-170395
PMID:28922157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5676852/
Abstract

BACKGROUND

The value of fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and magnetic resonance imaging (MRI) for predicting conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD) in longer-term is unclear.

OBJECTIVE

To evaluate longer-term prediction of MCI to AD conversion using 18F-FDG-PET and MRI in a multicenter study.

METHODS

One-hundred and fourteen patients with MCI were followed for 5 years. They underwent clinical and neuropsychological examinations, 18F-FDG-PET, and MRI at baseline. PET images were visually classified into predefined dementia patterns. PET scores were calculated as a semi quantitative index. For structural MRI, z-scores in medial temporal area were calculated by automated volume-based morphometry (VBM).

RESULTS

Overall, 72% patients with amnestic MCI progressed to AD during the 5-year follow-up. The diagnostic accuracy of PET scores over 5 years was 60% with 53% sensitivity and 84% specificity. Visual interpretation of PET images predicted conversion to AD with an overall 82% diagnostic accuracy, 94% sensitivity, and 53% specificity. The accuracy of VBM analysis presented little fluctuation through 5 years and it was highest (73%) at the 5-year follow-up, with 79% sensitivity and 63% specificity. The best performance (87.9% diagnostic accuracy, 89.8% sensitivity, and 82.4% specificity) was with a combination identified using multivariate logistic regression analysis that included PET visual interpretation, educational level, and neuropsychological tests as predictors.

CONCLUSION

18F-FDG-PET visual assessment showed high performance for predicting conversion to AD from MCI, particularly in combination with neuropsychological tests. PET scores showed high diagnostic specificity. Structural MRI focused on the medial temporal area showed stable predictive value throughout the 5-year course.

摘要

背景

氟-18-氟代脱氧葡萄糖正电子发射断层扫描(18F-FDG-PET)和磁共振成像(MRI)在预测轻度认知障碍(MCI)向阿尔茨海默病(AD)转化方面的长期价值尚不清楚。

目的

在一项多中心研究中,评估 18F-FDG-PET 和 MRI 对 MCI 向 AD 转化的长期预测。

方法

114 例 MCI 患者随访 5 年。他们在基线时接受了临床和神经心理学检查、18F-FDG-PET 和 MRI。PET 图像根据预先设定的痴呆模式进行视觉分类。PET 评分被计算为半定量指标。对于结构 MRI,通过基于自动容积的形态计量学(VBM)计算内侧颞区的 z 分数。

结果

总体而言,72%的遗忘型 MCI 患者在 5 年内进展为 AD。5 年内 PET 评分的诊断准确性为 60%,敏感性为 53%,特异性为 84%。PET 图像的视觉解读预测 AD 转化率为 82%,总敏感性为 94%,特异性为 53%。VBM 分析的准确性在 5 年内波动不大,在 5 年随访时最高(73%),敏感性为 79%,特异性为 63%。使用多元逻辑回归分析识别的最佳组合(包括 PET 视觉解读、教育水平和神经心理学测试作为预测指标)的表现最佳(诊断准确性 87.9%,敏感性 89.8%,特异性 82.4%)。

结论

18F-FDG-PET 视觉评估对预测 MCI 向 AD 转化具有较高的性能,特别是与神经心理学测试相结合时。PET 评分具有较高的诊断特异性。以内侧颞区为重点的结构 MRI 在整个 5 年过程中具有稳定的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/d16f69d44dda/jad-60-jad170395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/367056794a48/jad-60-jad170395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/8a5429962d95/jad-60-jad170395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/ac3af85c7a34/jad-60-jad170395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/d16f69d44dda/jad-60-jad170395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/367056794a48/jad-60-jad170395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/8a5429962d95/jad-60-jad170395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/ac3af85c7a34/jad-60-jad170395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d56/5676852/d16f69d44dda/jad-60-jad170395-g004.jpg

相似文献

1
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.18F-FDG-PET 和磁共振成像对预测轻度认知障碍向阿尔茨海默病转化的价值的长期研究:一项多中心研究。
J Alzheimers Dis. 2017;60(3):877-887. doi: 10.3233/JAD-170395.
2
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.使用18F-FDG-PET对轻度认知障碍预后的预测:一项多中心研究。
J Alzheimers Dis. 2015;45(2):543-52. doi: 10.3233/JAD-141338.
3
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.FDG-PET 和 CSF 生物标志物在大型多中心 MCI 队列中预测向不同类型痴呆转化的准确性。
Neuroimage Clin. 2018 Jan 28;18:167-177. doi: 10.1016/j.nicl.2018.01.019. eCollection 2018.
4
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.在临床环境中,对轻度认知障碍患者进行氟代脱氧葡萄糖(FDG)和淀粉样蛋白正电子发射断层扫描(PET)生物标志物的交叉验证,以预测阿尔茨海默病所致痴呆的风险
J Alzheimers Dis. 2017;59(2):603-614. doi: 10.3233/JAD-170158.
5
Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI.基于生物标志物的痴呆进展预测:遗忘型轻度认知障碍的 F-18 FDG-PET。
Neurol India. 2019 Sep-Oct;67(5):1310-1317. doi: 10.4103/0028-3886.271245.
6
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.18F-FDG和淀粉样蛋白PET的视觉分析与全自动分析对轻度认知障碍患者阿尔茨海默病所致痴呆的预测作用
J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.
7
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.18F-FDG PET 预测轻度认知障碍患者向阿尔茨海默病痴呆的转化:一项更新的测试准确性系统综述。
J Alzheimers Dis. 2018;64(4):1175-1194. doi: 10.3233/JAD-171125.
8
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.使用 ADNI 的基线数据联合评估定量 18F-氟比他派和 18F-FDG 区域摄取。
J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.
9
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
10
The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.使用基于个体的 FDG-PET 感兴趣区容积预测从轻度认知障碍到痴呆的转化。
BMC Med Imaging. 2024 Mar 28;24(1):75. doi: 10.1186/s12880-024-01256-x.

引用本文的文献

1
Efficacy of computerized cognitive training using mobile devices to promote cognitive functioning in community-dwelling older adults with or without risk of mild cognitive impairment: A multi-centre longitudinal study.使用移动设备进行计算机化认知训练对促进有或无轻度认知障碍风险的社区老年人认知功能的疗效:一项多中心纵向研究。
Digit Health. 2025 Aug 11;11:20552076251362117. doi: 10.1177/20552076251362117. eCollection 2025 Jan-Dec.
2
Visual perception and cognitive functioning in MCI and mild Alzheimer's disease: a cross-sectional study protocol from the DEM-VIS study in Germany.轻度认知障碍和轻度阿尔茨海默病中的视觉感知与认知功能:德国DEM-VIS研究的一项横断面研究方案
BMJ Open. 2025 Aug 6;15(8):e096950. doi: 10.1136/bmjopen-2024-096950.
3

本文引用的文献

1
Suspected non-Alzheimer disease pathophysiology--concept and controversy.疑似非阿尔茨海默病的病理生理学——概念与争议
Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18.
2
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.使用18F-FDG-PET对轻度认知障碍预后的预测:一项多中心研究。
J Alzheimers Dis. 2015;45(2):543-52. doi: 10.3233/JAD-141338.
3
Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.
My patient might be depressed - can I still screen for MCI? Exploring cognitive performance on the MoCA in older people screened for depressive symptoms with the PHQ-9.我的患者可能患有抑郁症——我还能筛查轻度认知障碍(MCI)吗?探讨使用PHQ-9筛查出有抑郁症状的老年人在蒙特利尔认知评估量表(MoCA)上的认知表现。
BMC Geriatr. 2025 May 24;25(1):374. doi: 10.1186/s12877-025-06004-6.
4
The use of outpatient support services: Differences between people with mild cognitive impairment and people with mild to moderate dementia.门诊支持服务的使用:轻度认知障碍患者与轻度至中度痴呆患者之间的差异。
J Alzheimers Dis. 2025 Mar;104(1):73-82. doi: 10.1177/13872877251314060. Epub 2025 Jan 28.
5
The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment.实践出真知:患者参与轻度认知障碍中大麻二酚的研究。
BMC Complement Med Ther. 2025 Jan 22;25(1):19. doi: 10.1186/s12906-025-04753-w.
6
Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study).个体化计算机认知训练(iCCT)对社区轻度认知障碍(MCI)人群的认知影响:一项随机对照试验(MCI-CCT 研究)干预 6 个月期间的认知结果。
BMC Med. 2024 Oct 15;22(1):472. doi: 10.1186/s12916-024-03647-x.
7
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.分子成像方法在预测轻度认知障碍向痴呆进展中的诊断性能:一项更新的系统评价
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1876-1890. doi: 10.1007/s00259-024-06631-y. Epub 2024 Feb 15.
8
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study.阿尔茨海默病患者脑脊液中淀粉样蛋白-β 42、淀粉样蛋白-β 40 与淀粉样蛋白-β 42/40 与可溶性磷酸化 tau 及疾病负担的相关性不同:一项脑脊液与氟代脱氧葡萄糖正电子发射断层扫描研究。
Alzheimers Res Ther. 2023 Aug 30;15(1):144. doi: 10.1186/s13195-023-01291-w.
9
Are Protective Activities and Limitations in Practical Skills of Daily Living Associated with the Cognitive Performance of People with Mild Cognitive Impairment? Baseline Results from the BrainFit-Nutrition Study.保护活动和日常生活实践技能限制与轻度认知障碍患者的认知表现有关吗?来自 BrainFit-Nutrition 研究的基线结果。
Nutrients. 2023 Aug 10;15(16):3519. doi: 10.3390/nu15163519.
10
Elevated serum platelet count inhibits the effects of brain functional changes on cognitive function in patients with mild cognitive impairment: A resting-state functional magnetic resonance imaging study.血清血小板计数升高抑制轻度认知障碍患者脑功能变化对认知功能的影响:一项静息态功能磁共振成像研究。
Front Aging Neurosci. 2023 Mar 27;15:1088095. doi: 10.3389/fnagi.2023.1088095. eCollection 2023.
遗忘型轻度认知障碍中18F-FDG-PET的视觉与半定量分析:一项欧洲阿尔茨海默病协会(EADC)项目
J Alzheimers Dis. 2015;44(3):815-26. doi: 10.3233/JAD-142229.
4
Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study.(123)I-IMP-CBF SPECT 预测 MCI 患者的结局:一项多中心前瞻性队列研究。
Ann Nucl Med. 2013 Dec;27(10):898-906. doi: 10.1007/s12149-013-0768-7. Epub 2013 Sep 6.
5
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.采用联合脑脊液、磁共振成像和正电子发射断层扫描(PET)生物标志物预测阿尔茨海默病高危人群的认知能力下降。
Radiology. 2013 Feb;266(2):583-91. doi: 10.1148/radiol.12120010. Epub 2012 Dec 11.
6
Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease.基于 SPM8 的自动体素形态计量学和通过指数李代数的可变形解剖配准对结构 MRI 的分析有助于提高可能的阿尔茨海默病的诊断。
AJNR Am J Neuroradiol. 2012 Jun;33(6):1109-14. doi: 10.3174/ajnr.A2935. Epub 2012 Feb 2.
7
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.评估校准的(18)F-FDG PET 评分作为阿尔茨海默病和轻度认知障碍进展的生物标志物。
J Nucl Med. 2011 Aug;52(8):1218-26. doi: 10.2967/jnumed.111.090902. Epub 2011 Jul 15.
8
Comparing predictors of conversion and decline in mild cognitive impairment.比较轻度认知障碍转归和衰退的预测因素。
Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.
9
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies.阿尔茨海默病的神经结构预测因子:基于体素形态测量学研究的荟萃分析。
Neurobiol Aging. 2011 Oct;32(10):1733-41. doi: 10.1016/j.neurobiolaging.2009.11.008. Epub 2009 Dec 11.
10
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).FDG PET 对两个独立多中心样本(NEST-DD 和 ADNI)中阿尔茨海默病的检测性能。
Dement Geriatr Cogn Disord. 2009;28(3):259-66. doi: 10.1159/000241879. Epub 2009 Sep 25.